Cargando…
Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation
Autores principales: | Yanagiya, Ryo, Wanezaki, Masahiro, Toubai, Tomomi, Watanabe, Masafumi, Ishizawa, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037003/ https://www.ncbi.nlm.nih.gov/pubmed/35871590 http://dx.doi.org/10.2169/internalmedicine.0482-22 |
Ejemplares similares
-
Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation
por: Yanagiya, Ryo, et al.
Publicado: (2022) -
Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation
por: Henmi, Heisuke, et al.
Publicado: (2022) -
Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023) -
Resolution of Sinus Tachycardia Secondary to Hyperthyroidism With Ivabradine
por: Medina, Yelizaveta, et al.
Publicado: (2023) -
Successful treatment of acute pancreatitis associated with late-onset acute liver GVHD after second allogeneic hematopoietic cell transplantation
por: Hosokawa, Yuka, et al.
Publicado: (2022)